AppriseMD Blog
THE CHALLENGE Last year, several payers implemented or announced some tactical changes in their provider reimbursement policies. The providers took a hit with these evaluation and management (E/M) downcoding programs, resulting in lower-tier payments to providers if the payers disagreed with the severity of the patients’ illnesses. Regulatory review has sidelined the rollout of some […]
White Papers

The financial impact of the IPO list magnified with the rise of CMS-4201-F, giving rise to inpatient reimbursement for all MAO patients who require services designated on the IPO list. Hospitals need to ensure that the proper setting is scheduled when any Medicare or MA patient undergoes a procedure designated on the IPO list, and they should also follow any proposed additions and removals to the list closely to ensure appropriate treatment and reimbursement.
Case Studies
THE CHALLENGE In 2025, inpatient (IP) and outpatient healthcare claim denials increased by 12% and 14% respectively and the average amount per claim increased by 18%1, forcing hospitals to address payer denials head-on. Most health systems deploy a multi-prong approach to ensure appropriate reimbursement, including outsourcing at least a portion of their revenue cycle operations. […]
